Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/advances-in-cancer-research/vande-woude/descriptif_3571616
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3571616

Advances in Cancer Research Genomics in Cancer Drug Discovery and Development

Langue : Anglais

Directeurs de Collection : Vande Woude George F., Klein George

Couverture de l’ouvrage Advances in Cancer Research
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever thematic volume in the series, focusing on the topic of genomics in cancer drug development. The chapters included in this book represent the cutting-edge information in the field and span such topics as Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics; Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches; The Application of siRNA Technology to Cancer Biology Discovery; Ribozyme Technology for Cancer Gene Target Identification and Validation; Cancer Cell-Based Genomic and Small Molecule Screens; Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines; Practices and Pitfalls of Mouse Cancer Models in Drug Discovery; Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development ? Quantification of Emerging Protein Biomarkers; Molecular Optical Imaging of Therapeutic Targets of Cancer; Cancer Drug Approval in the United States, Europe and Japan.
Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics.
Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches.
The Application of siRNA Technology to Cancer Biology Discovery.
Ribozyme Technology for Cancer Gene Target Identification and Validation.
Cancer Cell-Based Genomic and Small Molecule Screens.
Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines.
Practices and Pitfalls of Mouse Cancer Models in Drug Discovery.
Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers.
Molecular Optical Imaging of Therapeutic Targets of Cancer.
Cancer Drug Approval in the United States, Europe and Japan.
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.

Date de parution :

Ouvrage de 432 p.

15x22.8 cm

Sous réserve de disponibilité chez l'éditeur.

158,56 €

Ajouter au panier

Thème d’Advances in Cancer Research :